Skin Cancer

>

Latest News

Green and pink model of a melanoma cell
NCCN Guidelines Update Includes HEPZATO KIT for Uveal Melanoma

February 25th 2025

Updates to the NCCN guidelines recommend HEPZATO KIT for use in hepatic-dominant uveal melanoma as a Category 2A treatment option.

Illustration of a clipboard with the word "Guidelines" on top of the page, followed by a check list
NCCN Guideline Updates on ctDNA Stance in MCC and Colon, Rectal Cancer

February 22nd 2025

dark blue background with a white outline indicating layers of skin
Cemiplimab as Adjuvant Therapy Improves DFS in High-Risk Cutaneous Squamous Cell Carcinoma

January 20th 2025

Image of FDA on a clipboard.
Cosibelimab Approved by FDA for Metastatic, Locally Advanced Cutaneous Squamous Cell Carcinoma

December 13th 2024

FDA on clipboard
Accelerated Approval Sought for RP1-Nivolumab Combo for Pretreated Melanoma

November 24th 2024

Latest CME Events & Activities

More News